Find the latest pharmaceutical market place for formulations enquiry about Omalizumab on PharmaCompass.com.

Various FDFs needed in Greece [ENA25067]

A company that focuses on marketing and distribution of OSDs and liquids is looking for suppliers of Various FDFs for commercial purposes. The suppliers must support this enquiry with dossiers.
1. Ferric Carboxymaltose Injections
2. Methotrexate Injections
3. Denosumab Solution for Injections
4. Omalizumab Solution for Injections

Reply

15 Jan 2026

Tender// Various Finished Dosage Formulations needed in Poland [ENA11699]

Provincial Specialist Hospital in Wroclaw is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 16-Nov-2021.
1. Secukinumab (150 mg/ ml) Solution for Injections. The required quantity is 170 units.
2. Ixekizumab (80 mg/ ml) Solution for Injections. The required quantity is 50 units.
3. Omalizumab (150 mg/ ml) Solution for Injections. The required quantity is 120 units.

Reply

20 Oct 2021

india-flag Flag

Various Finished Dosage Formulations needed in India [ENA07321]

RKD Pharmaceutical, a distributor company that deals in pharmaceutical products is looking for suppliers of Various Finished Dosage Formulations. Interested suppliers can contact them via their email: rangan@rkdpharma.com.
1. Adalimumab 40 mg/0.8 ml Injection
2. Bevacizumab 400 mg/16 ml injection
3. Cetuximab 2 mg/ml Injection
4. Infliximab 100 mg Injection
5. Omalizumab 150 mg/ml Injection

Reply

18 May 2020

United_States_of_America Flag

Omalizumab and Dornase alpha formulations needed for the US market [ENA02794]

A leading global pharmaceutical company is looking for manufacturers who can supply or are developing Omalizumab and Dornase alpha formulations for the US market.

Reply

30 Nov 2018

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.